A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care

被引:46
|
作者
Blak, B. T. [1 ]
Smith, H. T. [2 ]
Hards, M. [1 ]
Maguire, A. [3 ]
Gimeno, V. [4 ]
机构
[1] Cegedim Strateg Data Med Res Ltd, London NW1 0QG, England
[2] Lilly UK, Erl Wood Manor, Windlesham, Surrey, England
[3] United BioSource Corp, Ctr Epidemiol & Database Analyt, London, England
[4] Lundbeck, Barcelona, Spain
关键词
Insulin treatment; Type; 2; diabetes; Primary Care; TO-TARGET TRIAL; NPH INSULIN; THERAPY; MELLITUS; PEOPLE; AGENTS; VALIDATION; MANAGEMENT; SECRETION; ALGORITHM;
D O I
10.1111/j.1464-5491.2012.03694.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabet. Med. 29, e191e198 (2012) Abstract Aims This study characterized UK primary care patients with Type 2 diabetes who initiated insulin treatment, and described the initial insulin regimens used, overall metabolic changes and health-care resource usage. Methods A retrospective cohort study was performed using quality-checked patient data from The Health Improvement Network database. Eligible patients who initiated insulin for the first time between 2004 and 2006 were grouped into four cohorts according to the type of insulin regimen initiated. Data on patient characteristics, metabolic and clinical outcomes and health-care resource use were collected at baseline and during 6 months of follow-up. Results In total, 4045 eligible adults [2269 male, 1776 female; mean age 62.6 +/- 13.3 years; mean baseline HbA1c 82 +/- 22 mmol/mol (9.6% +/- 2.0%)] initiated insulin. Approximately half (52.4%) initiated insulin as basal insulin only, 41.6% as premixed only, 4.0% as basal-bolus and 2.1% as prandial insulin only. Among patients with = 180 days follow-up (n = 3815), the initial insulin regimen was not changed during follow-up in 75.1% of patients, while 13.7% discontinued, 7.0% switched and 4.7% intensified insulin therapy. The mean change in HbA1c was -14 mmol/mol (-1.3%, n = 2881), with 17.3% of patients achieving an HbA1c of < 53 mmol/mol (7%, n = 3024). The mean weight change was +0.9 kg (n = 2345). Conclusions Basal and premixed insulin were the most common types of insulin initiated and in most patients no changes were made to the initial regimen over 6 months. However, few patients achieved glycemic control targets.
引用
收藏
页码:E191 / E198
页数:8
相关论文
共 50 条
  • [1] Primary Care Physicians Opinion on Insulin Initiation in Type 2 Diabetes Patients
    Sreedhar, D.
    Ligade, Virendra S.
    Janodia, Manthan D.
    Pise, Ajay G.
    Udupa, N.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (10) : 1515 - 1516
  • [2] Changes in time to insulin initiation in type 2 diabetes patients: A retrospective database analysis in Germany and UK (2005-2010)
    Kostev, Karel
    Rathmann, Wolfgang
    PRIMARY CARE DIABETES, 2013, 7 (03) : 229 - 233
  • [3] Longitudinal change in HbA1c after insulin initiation in primary care patients with type 2 diabetes: A database analysis in UK and Germany
    Rathmann, Wolfgang
    Strassburger, Klaus
    Tamayo, Teresa
    Kostev, Karel
    PRIMARY CARE DIABETES, 2012, 6 (01) : 47 - 52
  • [4] Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: A retrospective database analysis
    Kostev, Karel
    Dippel, Franz-Werner
    Rathmann, Wolfgang
    PRIMARY CARE DIABETES, 2014, 8 (02) : 127 - 131
  • [5] Insulin initiation for type 2 diabetes mellitus in primary care
    Melanie J. Davies
    Sudesna Chatterjee
    Nature Reviews Endocrinology, 2017, 13 : 317 - 318
  • [6] Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
    Hayes, R. P.
    Fitzgerald, J. T.
    Jacober, S. J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (06) : 860 - 868
  • [7] Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: A retrospective database analysis in Germany, France, and UK
    Kostev, Karel
    Rathmann, Wolfgang
    PRIMARY CARE DIABETES, 2013, 7 (02) : 167 - 171
  • [8] An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol
    Irene D Blackberry
    John S Furler
    Louise E Ginnivan
    Hanan Derraz
    Alicia Jenkins
    Neale Cohen
    James D Best
    Doris Young
    Danny Liew
    Glenn Ward
    Jo-Anne Manski-Nankervis
    David N O’Neal
    BMC Family Practice, 15
  • [9] An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol
    Blackberry, Irene D.
    Furler, John S.
    Ginnivan, Louise E.
    Derraz, Hanan
    Jenkins, Alicia
    Cohen, Neale
    Best, James D.
    Young, Doris
    Liew, Danny
    Ward, Glenn
    Manski-Nankervis, Jo-Anne
    O'Neal, David N.
    BMC FAMILY PRACTICE, 2014, 15
  • [10] Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care
    Nyeland, M. E.
    Ploug, U. J.
    Richards, A.
    Alvarez, L. Garcia
    Demuth, D.
    Muthutantri, A.
    Skovgaard, R.
    Evans, M.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2015, 69 (03) : 281 - 291